Journal of Antimicrobial Chemotherapy (2000) 45, 421-431
© 2000 The British Society for Antimicrobial Chemotherapy
Tn551-mediated insertional inactivation of the fmtB gene encoding a cell wall-associated protein abolishes methicillin resistance in Staphylococcus aureus
a Department of Microbiology, Hiroshima University School of Dentistry, Kasumi 1-2-3, Minami-ku, Hiroshima City, Hiroshima 734-8553, Japan; b Institute for Medical Microbiology, University of Zürich, Gloriastr. 32, CH-8028 Zürich, Switzerland
A Tn551 insert in a gene termed fmtB was shown to reduce oxacillin as well as Triton X-100 resistance in highly methicillin-resistant Staphylococcus aureus (MRSA) COL. Backcrosses of fmtB::Tn551 into S. aureus COL and into two genetically distinct MRSA strains, KSA8 and NCTC10443, confirmed the linkage of fmtB::Tn551 with loss of oxacillin resistance. The fmtB gene codes for a protein of a deduced molecular mass of 263 kDa that contains 17 tandem repeats of 75 amino acids and a C-terminal LPXTG cell wall-sorting motif. Immunoblots with anti-FmtB antibodies confirmed its localization in the cell wall fraction. The fmtB gene was mapped downstream of the phosphoglucosamine mutase operon glmM which catalyses formation of glucosamine-1-phosphate. Oxacillin resistance was not restored in fmtB mutants by trans-complementation with fmtB. However, although GlmM production was not affected by fmtB inactivation, oxacillin resistance was increased in fmtB mutants by introducing a plasmid-borne glmM gene, presumably by GlmM overexpression. Interestingly, a similar phenotypic complementation was obtained in fmtB mutants by including substrate level concentrations of N-acetylglucosamine or glucosamine in the growth medium. Inactivation of the fmtB gene seems therefore to have an indirect effect on methicillin resistance which can be relieved by increasing the production of the cell wall precursor glucosamine-1-phosphate.
Corresponding author. Tel: +81-82-257-5636; Fax: +81-82-257-5639; e-mail: hkomatsu{at}ipc.hiroshima-u.ac.jp
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. M.-L. Sung, D. H. Lloyd, and J. A. Lindsay Staphylococcus aureus host specificity: comparative genomics of human versus animal isolates by multi-strain microarray Microbiology, July 1, 2008; 154(7): 1949 - 1959. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Ouhara, H. Komatsuzawa, T. Kawai, H. Nishi, T. Fujiwara, Y. Fujiue, M. Kuwabara, K. Sayama, K. Hashimoto, and M. Sugai Increased resistance to cationic antimicrobial peptide LL-37 in methicillin-resistant strains of Staphylococcus aureus J. Antimicrob. Chemother., June 1, 2008; 61(6): 1266 - 1269. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Fan, Y. Liu, D. Smith, L. Konermann, K. W. M. Siu, and D. Golemi-Kotra Diversity of Penicillin-binding Proteins: RESISTANCE FACTOR FmtA OF STAPHYLOCOCCUS AUREUS J. Biol. Chem., November 30, 2007; 282(48): 35143 - 35152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Renzoni, C. Barras, P. Francois, Y. Charbonnier, E. Huggler, C. Garzoni, W. L. Kelley, P. Majcherczyk, J. Schrenzel, D. P. Lew, et al. Transcriptomic and Functional Analysis of an Autolysis-Deficient, Teicoplanin-Resistant Derivative of Methicillin-Resistant Staphylococcus aureus. Antimicrob. Agents Chemother., September 1, 2006; 50(9): 3048 - 3061. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. J. B. Sibbald, A. K. Ziebandt, S. Engelmann, M. Hecker, A. de Jong, H. J. M. Harmsen, G. C. Raangs, I. Stokroos, J. P. Arends, J. Y. F. Dubois, et al. Mapping the Pathways to Staphylococcal Pathogenesis by Comparative Secretomics Microbiol. Mol. Biol. Rev., September 1, 2006; 70(3): 755 - 788. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. McAleese, S. W. Wu, K. Sieradzki, P. Dunman, E. Murphy, S. Projan, and A. Tomasz Overexpression of Genes of the Cell Wall Stimulon in Clinical Isolates of Staphylococcus aureus Exhibiting Vancomycin-Intermediate- S. aureus-Type Resistance to Vancomycin J. Bacteriol., February 1, 2006; 188(3): 1120 - 1133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Bowden, W. Chen, J. Singvall, Y. Xu, S. J. Peacock, V. Valtulina, P. Speziale, and M. Hook Identification and preliminary characterization of cell-wall-anchored proteins of Staphylococcus epidermidis Microbiology, May 1, 2005; 151(5): 1453 - 1464. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Dryla, S. Prustomersky, D. Gelbmann, M. Hanner, E. Bettinger, B. Kocsis, T. Kustos, T. Henics, A. Meinke, and E. Nagy Comparison of Antibody Repertoires against Staphylococcus aureus in Healthy Individuals and in Acutely Infected Patients Clin. Vaccine Immunol., March 1, 2005; 12(3): 387 - 398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Robinson and M. C. Enright Evolutionary Models of the Emergence of Methicillin-Resistant Staphylococcus aureus Antimicrob. Agents Chemother., December 1, 2003; 47(12): 3926 - 3934. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Midorikawa, K. Ouhara, H. Komatsuzawa, T. Kawai, S. Yamada, T. Fujiwara, K. Yamazaki, K. Sayama, M. A. Taubman, H. Kurihara, et al. Staphylococcus aureus Susceptibility to Innate Antimicrobial Peptides, {beta}-Defensins and CAP18, Expressed by Human Keratinocytes Infect. Immun., July 1, 2003; 71(7): 3730 - 3739. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. M. Roche, R. Massey, S. J. Peacock, N. P. J. Day, L. Visai, P. Speziale, A. Lam, M. Pallen, and T. J. Foster Characterization of novel LPXTG-containing proteins of Staphylococcus aureus identified from genome sequences Microbiology, March 1, 2003; 149(3): 643 - 654. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Clarke, L. G. Harris, R. G. Richards, and S. J. Foster Analysis of Ebh, a 1.1-Megadalton Cell Wall-Associated Fibronectin-Binding Protein of Staphylococcus aureus Infect. Immun., December 1, 2002; 70(12): 6680 - 6687. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Cordwell, M. R. Larsen, R. T. Cole, and B. J. Walsh Comparative proteomics of Staphylococcus aureus and the response of methicillin-resistant and methicillin-sensitive strains to Triton X-100 Microbiology, September 1, 2002; 148(9): 2765 - 2781. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Avison, P. M. Bennett, R. A. Howe, and T. R. Walsh Preliminary analysis of the genetic basis for vancomycin resistance in Staphylococcus aureus strain Mu50 J. Antimicrob. Chemother., February 1, 2002; 49(2): 255 - 260. [Abstract] [Full Text] [PDF]
|
|